Friday, August 06, 2004

Lilly to disclose drug trial results on the Web
USA Today story - "Responding to an "erosion" of public trust in drug trial data, Eli Lilly and Co. promised Tuesday to post online the research results — good and bad — for every drug it sells. Lilly said it will provide clinical data on the safety and effectiveness of each of its government-approved drugs on the Web by the end of the year..."  
  

Child Health Disparities: Framing a Research Agenda
A report (in Adobe Acrobat format) from the Commonwealth Fund that appeared in the July/August issue of Ambulatory Pediatrics - " Children are affected by widespread disparities in health status and in the quality of the health care they receive. Given the increasing number of minority children in the U.S., research on these disparities is very important. Paying heed to the inequalities in child health research, however, is easier said than done. ...  
  

NIH to Set Stiff Restrictions on Outside Consulting
Washington Post story - "A top official at the National Institutes of Health yesterday detailed restrictions and disclosure requirements soon to be imposed on agency scientists who wish to consult for outside companies -- a response to a string of embarrassing revelations about lucrative contracts and other apparent conflicts of interest. The new oversight system, which officials expect to be in place within six months, will ban anyone with even indirect authority over NIH grants from consulting for drug or biotechnology companies. It will also place limits on stock ownership and require that more details of approved outside activities be open to the public..."